Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas

Lu, Hezhe,Liu, Shujing,Zhang, Gao,Wu, Bin,Zhu, Yueyao, Frederick, Dennie T.,Hu, Yi,Zhong, Wenqun,Randell, Sergio,Sadek, Norah,Zhang, Wei, Chen, Gang,Cheng, Chaoran,Zeng, Jingwen, Wu, Lawrence W.,Zhang, Jie,Liu, Xiaoming,Xu, Wei,Krepler, Clemens,Sproesser, Katrin, Xiao, Min,Miao, Benchun,Liu, Jianglan, Song, Claire D.,Liu, Jephrey Y., Karakousis, Giorgos C., Schuchter, Lynn M.,Lu, Yiling,Mills, Gordon,Cong, Yusheng,Chernoff, Jonathan,Guo, Jun, Boland, Genevieve M., Sullivan, Ryan J.,Wei, Zhi, Field, Jeffrey, Amaravadi, Ravi K., Flaherty, Keith T.,Herlyn, Meenhard,Xu, Xiaowei,Guo, Wei

Nature(2018)

引用 0|浏览1
暂无评分
摘要
In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.
更多
查看译文
关键词
Cancer therapeutic resistance,Cell signalling,Science,Humanities and Social Sciences,multidisciplinary
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要